BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 313947)

  • 1. Experimental allergic encephalomyelitis in the Lewis rat: studies on the mechanism of recovery from disease and acquired resistance to reinduction.
    Willenborg DO
    J Immunol; 1979 Sep; 123(3):1145-50. PubMed ID: 313947
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of paralytic experimental allergic encephalomyelitis in rats: susceptibility to active and passive disease reinduction.
    Hinrichs DJ; Roberts CM; Waxman FJ
    J Immunol; 1981 May; 126(5):1857-62. PubMed ID: 6163820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune effector cells. IV. Induction of experimental allergic encephalomyelitis in Lewis rats without adjuvant.
    Holda JH; Silberg D; Swanborg RH
    J Immunol; 1983 Feb; 130(2):732-4. PubMed ID: 6184402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental allergic encephalomyelitis in Lewis rats: inhibition by bacterial lipopolysaccharides and acquired resistance to reinduction by challenge with myelin basic protein.
    Raziuddin S; Kibler RF; Morrison DC
    J Immunol; 1981 Jul; 127(1):16-20. PubMed ID: 6165759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoptive transfer of experimental allergic encephalomyelitis: incubation of rat spleen cells with specific antigen.
    Richert JR; Driscoll BF; Kies MW; Alvord EC
    J Immunol; 1979 Feb; 122(2):494-6. PubMed ID: 84024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of self tolerance in experimental allergic encephalomyelitis. I. Differences between lymph node and spleen suppressor cells.
    Welch AM; Swierkosz JE; Swanborg RH
    J Immunol; 1978 Nov; 121(5):1701-5. PubMed ID: 309479
    [No Abstract]   [Full Text] [Related]  

  • 7. Transfer of allergic encephalomyelitis with spleen cells from donors sensitized with myelin basic protein in incomplete Freund's adjuvant.
    Namikawa T; Richert JR; Driscoll BF; Kies MW; Alvord EC
    J Immunol; 1982 Feb; 128(2):932-4. PubMed ID: 6172517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The response of the nude (athymic) rat to actively induced and adoptively transferred experimental allergic encephalomyelitis.
    Hinrichs DJ; Humphres RC
    J Immunol; 1983 Jul; 131(1):4-5. PubMed ID: 6190918
    [No Abstract]   [Full Text] [Related]  

  • 9. Recurrent experimental allergic encephalomyelitis in the Lewis rat.
    McFarlin DE; Blank SE; Kibler RF
    J Immunol; 1974 Aug; 113(2):712-5. PubMed ID: 4136044
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction of experimental allergic encephalomyelitis in suckling Lewis rats: role of age and type of sensitizing neuroantigen.
    Fujinami RS; Paterson PY
    J Immunol; 1977 Nov; 119(5):1634-8. PubMed ID: 72104
    [No Abstract]   [Full Text] [Related]  

  • 11. A suppressor T-lymphocyte cell line for autoimmune encephalomyelitis.
    Ellerman KE; Powers JM; Brostoff SW
    Nature; 1988 Jan; 331(6153):265-7. PubMed ID: 2447505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linkage of severity of experimental allergic encephalomyelitis to the rat major histocompatibility locus.
    Moore MJ; Singer DE; Williams RM
    J Immunol; 1980 Apr; 124(4):1815-20. PubMed ID: 6767774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental allergic encephalomyelitis supernatant transfer activity (EAE-STA) in Lewis rats:immunobiologic and initial biochemical properties.
    Whitacre CC; Paterson PY
    J Immunol; 1980 Apr; 124(4):1784-8. PubMed ID: 6965962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide plays a critical role in the recovery of Lewis rats from experimental autoimmune encephalomyelitis and the maintenance of resistance to reinduction.
    O'Brien NC; Charlton B; Cowden WB; Willenborg DO
    J Immunol; 1999 Dec; 163(12):6841-7. PubMed ID: 10586085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the refractoriness to reinduction of experimental allergic encephalomyelitis in Lewis rats that have recovered from one episode of the disease.
    MacPhee IA; Mason DW
    J Neuroimmunol; 1990 Apr; 27(1):9-19. PubMed ID: 1690754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quantitative assay for experimental allergic encephalomyelitis in the rat based on permeability of spinal cords to 125I-human gamma-globulin.
    Stohl W; Kaplan MS; Gonatas NK
    J Immunol; 1979 Mar; 122(3):920-5. PubMed ID: 87421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of experimental allergic encephalomyelitis. II. Appearance of suppressor cells during the remission phase of the disease.
    Welch AM; Holda JH; Swanborg RH
    J Immunol; 1980 Jul; 125(1):186-9. PubMed ID: 6155396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppression of experimental allergic encephalomyelitis. III. In vitro evidence for induction of suppressor T lymphocytes in draining lymph node cells of animals immunized with myelin basic protein complexed to lipopolysaccharides.
    Raziuddin S; Kibler RF; Morrison DC
    J Immunol; 1982 May; 128(5):2073-80. PubMed ID: 6174621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum IgM repertoire reactions to MBP/CFA immunization reflect the individual status of EAE susceptibility.
    Fesel C; Coutinho A
    J Autoimmun; 2000 Jun; 14(4):319-24. PubMed ID: 10882058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of recurrent experimental allergic encephalomyelitis with myelin basic protein.
    Panitch H; Ciccone C
    Ann Neurol; 1981 May; 9(5):433-8. PubMed ID: 6168235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.